Clinical Trial Details
EORTC-62971
Back to Clinical Trials Database
Randomized phase III trial of two investigational schedules of Ifosfamide versus standard dose Doxorubicin in patients with advanced or metastatic soft tissue sarcoma.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 13-Jan-1998 Date Step1 close: 05-Nov-2001 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 780 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00003212 |
| NCT number | NCT00003212 |
